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Abstract I Experimental 
Gas chromatographic-mass pectrometric (GC-MS) quantitation of 
25 cannabis sed oils determined Ag-tetrahydrocannabinol (THC) 
concentrations from 3 to 1500 pg/g oil. In a pilot study, the 
morning urine of six volunteers who had ingested 11 or 22 g of the 
oil, which contained the highest THC content (1500 pg/g), was 
collected for six days. The urine samples were screened by 
immunoassay, and the content of 11-nor-9-carboxy-Ag-THC 
(THCCOOH) was determined by GC-MS. Urine samples were 
found cannabis positive for up to six days with THCCOOH- 
equivalent concentrations up to 243 ng/ml, by the Abuscreen 
OnLine immunoassay and THCCOOH contents from 5 to 431 
ng/mL by the GC-MS method. All subjects reported THC-specific 
psychotropic effects. 
Introduction 
Hemp (Cannabis sativa L.) of the fiber type (< 0.5% ~9. 
tetrahydrocannabinol [THC]) or the drug type (> 0.5% THC) 
(1) can be legally cultivated inSwitzerland when used for indus- 
trial purposes but not for narcotic production. The Swiss Federal 
Office of Agriculture even sponsors farmers if they use 'seeds of 
controlled origin and of the fiber type. Inaddition, the products 
have to be manufactured and marketed by known companies. 
Stem fibers are used for textiles, ropes, construction material, and 
paper. The essential oil is added to cosmetics, and the seed fatty 
oil is processed to pharmaceutical, cosmetic, technical, and food 
products. Literature data about he THC content of cannabis 
seeds are rare. Hemphill et al. (2) reported that no cannabinoids 
were detectable in ungerminated cannabis seeds. 
In order to evaluate a possible psychotropic potency of 
cannabis seed oil, theTHC content of 25 oil samples was deter- 
mined by gas chromatography-mass spectrometry (GC-MS). 
The oil with the highest THC content was ingested by volunteers, 
their urine was screened by immunoassay, nd the content of 11- 
nor-9-carboxy-hg-THC (THCCOOH) was determined byGC-MS. 
* Author to whom correspondence should be addressed. 
Cannabis eed oil samples 
Ten cannabis seed oil samples wereobtained from different 
commercial sources in Switzerland (hemp shops, health food 
stores, oil manufacturers, farmers). Fifteen oils were produced 
in our laboratory using cannabis seeds of different types and ori- 
gins. Cannabis seed oil samples wer  kept refrigerated at 4~ 
until analyzed. 
Urine samples 
Cannabis seed oil (11 g [corresponding to 1 tablespoon or 12 
mL] and 22 g) with the highest THC content (1500 I~g/g) was 
administered in the evening as salad oil to six healthy volunteers. 
Their morning urine was collected over thefollowing six days 
and analyzed by Abuscreen OnLine (Roche Diagnostic Systems, 
Branchburg, N J) and GC-MS. The urine samples were frozen 
(-24~ until analyzed. 
Analytical procedures 
lmrnunoassay. Urine samples were analyzed by the Abuscreen 
OnLine assay according to the manufacturer's instructions (3) 
on a Cobas Mira Plus analyzer (Roche Diagnostic Systems, Basel, 
Switzerland). A calibration curve ranging from 0 to 150 ng/mL 
THCCOOH was generated using Abuscreen OnLi e cannabi- 
noids calibrators. Samples producing results > 150 ng/mLwere 
diluted 1:1 with twice-distilled water and reanalyzed. The cutoff 
value was set at 50 ng/mL. 
GC-MS. Cannabis seed oil samples werequantitated by the 
following method: 250 mg oil was spiked with 5 pg THC-d3 
(Radian, Austin, TX) as the internal standard nd rigorously 
shaken with 5 mL of methanol. The oil was eparated by 
freezing (-20~ for 8 h), and4 mL of the supernatant was 
evaporated to dryness. The residue was redissolved in 500 IJL of 
n-hexane and transferred onto a preconditioned 6-mL SiOH 
Bond Elut Certify (Varian, Harbor City, CA) solid-phase extrac- 
tion column. Cannabinoids were eluted with 5 mL of a mixture 
of n-hexane--diethylether (19:1), and  I~L was injected into 
the GC-MS. A DB-5MS capillary column (25m x 0.2-ram i.d.; 
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0.33-pm film thickness, J&W Scientific, Folson, CA), an HP 7673 
autosampler, and an HP 5890 series II GC with an HP 5972 mass 
selective detector were used. The oven temperature was initially 
held at 70~ for 1.15 min, increased to 120~ at 25~ then 
to 295~ at 12.5~ and held for 6 rain. Splitless injection was 
used at a temperature of 250~ 
THC peak identification was achieved by the comparison ofthe 
retention time (17.30 min) and the relative abundance of four 
characteristic confirming ions (rn/z 314, 299, 271, and 231) with 
the deuterated internal standard (m/z 317, 302, 274, and 234). 
Quantitation was based on the peak area of a single ion (m/z 
314) versus the peak area of the corresponding ion of the deuter- 
ated internal standard (m/z 317). The limit of quantitation was 
1 lag/g seed oil. The coefficient of variation at a concentration f 
20 pg/g was 6.1% (n = 6). 
The content of THC acid A in the cannabis seed oils was deter- 
mined at the same conditions as mentioned above but by online 
derivatization (Methelute, Pierce, Rockford, IL) at an injector 
temperature of 225~ THC acid A reference material was isolated 
according to (4). 
Urine samples were quantitated as follows: 4 mL urine was 
spiked with 200 ng THCCOOH-d3 (Research Triangle Institute, 
Research Triangle Park, NC) as the internal standard. KOH 
(270 laL, 10M) was added, and the urine was hydrolyzed in a water 
bath (60~ for 15 min). The urine was then adjusted to pH 4.5 with 
700 laL glacial acetic acid and subsequently extracted with a 3-mL 
C18 SPEC microcolumn disc of 15-mg sorbent weight (Ansys, 
Irvine, CA). The disc was washed with 1 mL diluted acetic acid 
(20%), dried under vacuum, and transferred into a vial. Acetonitrile 
(50 pL) and 50 laL bis(trimethylsilyl)trifluoroacetamide with 1% 
trimethylchlorosilane were added, and the disc was derivatized at 
60~ for 15 rain. The disc was dried under a stream of nitrogen and 
extracted with 100 IJL n-hexane in an ultrasonic bath. After filtra- 
tion, a 2-1~L aliquot of the extract was injected into a DB-5 MS cap- 
illary column (25 m x 0.2-mm i.d.; 0.33-pro film thickness, J&W 
Scientific). The same instrumentation as mentioned previously was 
used. The oven temperature was initially held at 200~ for 1 min, 
increased to 280~ at 15~ and held for 12 min. Splitless 
injection was performed at a temperature of 260~ 
Identification of THCCOOH was based on the comparison of 
retention time (16.59 rain) and relative abundance ofthree char- 
acteristic onfirming ions (m/z 371, 473, and 488) with the 
deuterated internal standard (m/z 374, 476, and 491). 
Quantitation was based upon the peak area of
a single ion (m/z 371) versus the peak area of 
the corresponding ion of the deuterated internal 
standard (ra/z 374). The limit of quantitation 
was 1 ng/mL. The coefficient of variation deter- 
mined at a concentration f 50 ng/mL was 6.8% 
(n = 6). The cutoff value was set at 15 ng/mL. 
Resulls and Discussion 
Cannabis seed oil analysis 
The THC content of 25 cannabis eed oil 
samples analyzed ranged from 3 to 1500 pg/g. 
There was only one oil with an extraordinarily high THC con- 
tent. This must have been due to an inappropriate harvesting 
technique resulting in a contamination f the seeds with the 
THC-rich leaflets. Of the oils, 88% showed THC levels below the 
tolerated maximum concentration f 50 lag/g fixed by the Swiss 
Federal Office of Public Health (5). All 15 oils prepared in our 
laboratory from fiber-type and from drug-type cannabis eeds 
had THC contents of 30 pg/g or less, whereas 30% of the com- 
mercially available oils had contents above the maximum tol- 
erated value. Seed samples of the cannabis fiber type recom- 
mended for cultivation by the Swiss Federal Office of 
Agriculture showed THC contents of 10 pg/g or less. The 
amount of THC acid A, the major cannabinoid in fresh-drug- 
type cannabis plants (1), which was decarboxylated in the GC 
injector to THC, in the oil samples was less than 10% of the 
respective THC content. 
Psychotropic effects 
All six subjects reported THC-specific psychotropic symp- 
toms starting 90 to 150 min after ingestion of cannabis eed oil 
and lasting 8 to 16 h (subjective qualitative statements). The 
typical THC effects were time distortion, increased acoustic 
perception, light confusion, and drowsiness. 
Urine analysis 
Twelve hours after ingestion of 11 and 22 g cannabis eed oil, 
which corresponded to doses of 16.5 and 33 mg THC (0.23 to 
0.56 mg THC per kg body weight), respectively, all six subjects 
Table I. Number of Cannabis-Positive Urine Samples (n -- 6) 
After Ingestion of 11g or 22 g of Cannabis Seed Oil 
(Corresponding to 16.5 mg or 33 mg THC) Determined 
by Abuscreen OnLine and GC-MS 
Time after ingestion (h) Abuscreen OnLine* GC-MS ~ 
0 0 0 
12 6 6 
36 6 6 
60 6 6 
84 3 5 
108 2 2 
132 1 2 
* Cutoff 50 ng/mL 
Cutoff 15 ng/mL, 
Table II. Urine THCCOOH Concentrations (ng/mL) after Ingestion of 11 g and 
22 g of Cannabis Seed Oil as Analyzed by GC-MS* 
Subjects 
Time after ingestion (h) 1 2 3 4 5 6 
0 0 0 0 0 0 0 
12 298 378 280 81 431 281 
36 154 186 121 104 242 263 
60 65 71 77 54 57 213 
84 35 30 78 10 49 69 
108 12 13 31 13 12 46 
132 11 9 24 6 5 30 
"Subjects 1-3 ingested 22 g cannabis eed oil, and subjects 4-6 ingested 1! g cannabis eed oil. 
374 
Journal of Analytical Toxicology, Vol. 21, September 1997 
showed positive r sults with the Abuscreen OnLine 
immunoassay showing THCCOOH-equivalent levels between 
171 and 243 ng/mL urine. After 60 h, all subjects still had con- 
centrations above the cutoff of 50 ng/mL. Creatinine was not 
determined. 
All immunoassay results could be verified by GC-MS with 
THCCOOH concentrations from 5 to 431 ng/mL. Some negative 
immunoassay results 84 h and longer after ingestion still 
showed positive THCCOOH levels with the GC-MS method 
(Tables I and II). This is in accordance with the findings of 
other authors (6,7) and is due to the hydrolysis of THCCOOH 
glucuronides before GC-MS and unknown crossreactivity of 
these conjugated metabolites with the Abuscreen OnLine 
reagents. 
Neither the immunoassay nor the GC-MS results correlated 
with the dosage of THC. A 22-g aliquot of cannabis seed oil of 
50-pg/g THC (officially tolerated maximum content) would 
result in an ingestion of 1.1 mg THC. Considering the oral 
bioavailability of THC of about 5-20% (8,9), 55-220 pg THC 
would theoretically be absorbed by the body. This dosage cer- 
tainly would be psychotropically inactive but could possibly 
produce a cannabinoid positive urine level. Giroud and Rivier 
(10) found radioimmunoassay-positive THCCOOH urine con- 
centrations (cutoff, 50 ng/mL) after an oral ingestion of 36 g of 
cannabis seed oil with a THC content of 10 pg/g. The GC-MS 
and Abuscreen Online levels were below th  cutoffs. 
Conclusion 
We conclude that cannabis seed oil produced from properly 
collected and processed cannabis seeds contains very low 
amounts of THC. An oil produced from resin-contaminated 
seeds may have a THC content high enough to cause typical 
THC effects and cannabis-positive immunoassay results. 
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